RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
7.25
+0.05 (0.69%)
At close: Apr 24, 2026, 4:00 PM EDT
7.25
0.00 (0.00%)
Pre-market: Apr 27, 2026, 8:24 AM EDT
RxSight Market Cap
RxSight has a market cap or net worth of $299.18 million as of April 27, 2026. Its market cap has decreased by -52.36% in one year.
Market Cap
299.18M
Enterprise Value
82.09M
1-Year Change
-52.36%
Ranking
Category
Stock Price
$7.25
Market Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has decreased from $424.33M to $299.18M, a decrease of -29.49%. That is a compound annual growth rate of -7.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 299.18M | -30.17% |
| Dec 31, 2025 | 428.44M | -69.08% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
| Jul 30, 2021 | 424.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cerus | 380.50M |
| Delcath Systems | 373.49M |
| Viemed Healthcare | 372.90M |
| ClearPoint Neuro | 353.24M |
| Standard BioTools | 350.87M |
| CapsoVision | 302.52M |
| Senseonics Holdings | 294.71M |
| TriSalus Life Sciences | 284.96M |